相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical Safety and Efficacy of Locoregional Therapy Combined with Adoptive Transfer of Allogeneic γδ T Cells for Advanced Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Tingting Zhang et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2022)
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma
Jiaojiao Guo et al.
CANCER GENE THERAPY (2021)
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
Yunfan Sun et al.
CELL (2021)
Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications
Andrew S. Mikhail et al.
EXPERT OPINION ON DRUG DELIVERY (2021)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH
Sabine Daemen et al.
CELL REPORTS (2021)
Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
Jingyi Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma
Junfeng Wang et al.
JOURNAL OF HEPATOLOGY (2021)
Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia-Sancho et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis
Gao Liu et al.
CELL DEATH & DISEASE (2021)
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma
Man Hsin Hung et al.
NATURE COMMUNICATIONS (2021)
Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
Nicola Tumino et al.
FRONTIERS IN IMMUNOLOGY (2021)
Complimenting the Complement: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Astha Malik et al.
FRONTIERS IN ONCOLOGY (2021)
Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
Xingxing Gao et al.
FRONTIERS IN ONCOLOGY (2021)
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
Amani Makkouk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz et al.
CANCERS (2021)
Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma
Oscar Wai Ho Yeung et al.
CANCERS (2021)
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou et al.
CANCERS (2021)
The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target
Xiangqian Guan et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
Andreas Koulouris et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine
Wei Shi et al.
CANCER LETTERS (2021)
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
Anat Shriki et al.
CANCER RESEARCH (2021)
IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1
Qin He et al.
HEPATOLOGY (2021)
Epithelial-Mesenchymal Transition (EMT) Induced by TGF-beta in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism
Jitka Soukupova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
Peter R. Galle et al.
LANCET ONCOLOGY (2021)
YAP-induced Ccl2 expression is associated with a switch in hepatic macrophage identity and vascular remodelling in liver cancer
Stefan Thomann et al.
LIVER INTERNATIONAL (2021)
Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma
Xiaoqin Zheng et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Zhengguo Wu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis et al.
CANCERS (2021)
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Ismahane Belhabib et al.
CANCERS (2021)
TGF-β1 Induces Immune Escape by Enhancing PD-1 and CTLA-4 Expression on T Lymphocytes in Hepatocellular Carcinoma
Shixiang Bao et al.
FRONTIERS IN ONCOLOGY (2021)
Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
Timothy C. Huber et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J. Casak et al.
CLINICAL CANCER RESEARCH (2021)
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Bishuang Cai et al.
CELL METABOLISM (2020)
Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response
Lu-Yu Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghba et al.
CELL COMMUNICATION AND SIGNALING (2020)
Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice
Yu Chen et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
Santosh K. Singh et al.
CANCERS (2020)
Inflammatory Mechanisms of HCC Development
Maria Grazia Refolo et al.
CANCERS (2020)
Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma
Masatoshi Kudo
CANCERS (2020)
Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human
Juanjuan Zhao et al.
CELL DISCOVERY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
Wenjie Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Tumor-Associated Macrophage Status in Cancer Treatment
Anna Maria Malfitano et al.
CANCERS (2020)
Complement factor H-deficient mice develop spontaneous hepatic tumors
Jennifer Laskowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Modern therapeutic approaches for the treatment of malignant liver tumours
Henrik Petrowsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study
Constanze Buhrmann et al.
MOLECULES (2020)
Three-Dimensional Culture System of Cancer Cells Combined with Biomaterials for Drug Screening
Teruki Nii et al.
CANCERS (2020)
Hepatocellular carcinoma: old friends and new tricks
Eunsun Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!
Boris Guiu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma
Jie Zhang et al.
CELL AND BIOSCIENCE (2020)
Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
Chiao-Fang Teng et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
Ningning Dong et al.
BRITISH JOURNAL OF CANCER (2019)
CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling
Yuan Zhang et al.
CANCER LETTERS (2019)
Lenvatinib: A Review in Hepatocellular Carcinoma
Zaina T. Al-Salama et al.
DRUGS (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
Jing Cao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
Andrea Baiocchini et al.
SCIENTIFIC REPORTS (2019)
Proteoglycans and Immunobiology of Cancer-Therapeutic Implications
George Tzanakakis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology
Joanna Mikulak et al.
FRONTIERS IN IMMUNOLOGY (2019)
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
Beatris Mastelic-Gavillet et al.
FRONTIERS IN IMMUNOLOGY (2019)
Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
Xuelian Xiong et al.
MOLECULAR CELL (2019)
The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review
Sarun Juengpanich et al.
TRANSLATIONAL ONCOLOGY (2019)
Macrophages and hepatocellular carcinoma
Zhiqiang Tian et al.
CELL AND BIOSCIENCE (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
Exhaustion of CD4+T-cells mediated by the Kynurenine Pathway in Melanoma
Soudabeh Rad Pour et al.
SCIENTIFIC REPORTS (2019)
Contextual Regulation of TGF-β Signaling in Liver Cancer
Shuo Tu et al.
CELLS (2019)
Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
Ren-Yu Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma
Mohammad Jafarnejad et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2019)
The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers
Matthias Bartneck et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Observational Study of PD-L1, TGF-β and Immune Cell Infiltrates in Hepatocellular Carcinoma
Christian Ihling et al.
FRONTIERS IN MEDICINE (2019)
STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration
Bin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation
Yuying Liu et al.
CANCER CELL (2018)
Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy
Ghulam Jilany Khan et al.
CURRENT DRUG TARGETS (2018)
Regorafenib: A Review in Hepatocellular Carcinoma
Young-A. Heo et al.
DRUGS (2018)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel et al.
HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity
Shishir Shetty et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Yao Wang et al.
ONCOIMMUNOLOGY (2018)
Effect of dendritic cell based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis
Cong Chen et al.
CYTOTHERAPY (2018)
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
Giorgia Marisi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
Sonya A. MacParland et al.
NATURE COMMUNICATIONS (2018)
Controlling aflatoxin contamination and propagation of Aspergillus flavus by a soy-fermenting Aspergillus oryzae strain
Ahmad F. Alshannaq et al.
SCIENTIFIC REPORTS (2018)
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Le-Xing Yu et al.
NPJ PRECISION ONCOLOGY (2018)
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Carolina Mendez-Blanco et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CART-Cell Therapy for Liver Cancer
Hong Liu et al.
CLINICAL CANCER RESEARCH (2017)
IL-6 Trans-Signaling Is Essential for the Development of Hepatocellular Carcinoma in Mice
Juri Bergmann et al.
HEPATOLOGY (2017)
A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment
Frederic Sierro et al.
IMMUNITY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
Pegah Golabi et al.
MEDICINE (2017)
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Y. Liu et al.
ONCOGENE (2017)
Liver Sinusoidal Endothelial Cell: An Update
Laurie D. DeLeve et al.
SEMINARS IN LIVER DISEASE (2017)
The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
Wei Yao et al.
SCIENTIFIC REPORTS (2017)
Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration
Annie Tosello-Trampont et al.
FRONTIERS IN IMMUNOLOGY (2017)
A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
Wenbo Yao et al.
EBIOMEDICINE (2017)
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Estela Maria Silva et al.
PLOS ONE (2017)
Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells
Hiroyuki Ogawa et al.
SCIENTIFIC REPORTS (2017)
Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance
Alexandra M. Stevens et al.
BLOOD ADVANCES (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Timothy Hardy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition
Wen-Hao Hu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma
Tai Hato et al.
IMMUNOTHERAPY (2016)
Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice
Lingxiang Kong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma
Yi Zhang et al.
JOURNAL OF PATHOLOGY (2016)
Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells
Erinn L. Soucie et al.
SCIENCE (2016)
Natural Killer Cells and Liver Fibrosis
Frank Fasbender et al.
FRONTIERS IN IMMUNOLOGY (2016)
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun et al.
ACTA PHARMACOLOGICA SINICA (2015)
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
Gaixia He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
A. Ali et al.
CELL DEATH & DISEASE (2015)
By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice
Weiqi Dai et al.
ONCOTARGET (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
Roles of Tumor Microenvironment in Hepatocelluar Carcinoma
Haeng R. Seo
CURRENT CANCER THERAPY REVIEWS (2015)
Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives
Jan Erik Slotta et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma
Loukia S. Poulou et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Huiping Gao et al.
CLINICAL CANCER RESEARCH (2014)
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2014)
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial
Andrew X. Zhu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Transarterial Chemoembolization and Radioembolization
Bruno Sangro et al.
SEMINARS IN LIVER DISEASE (2014)
Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
Ali Raza et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
Yan Wu et al.
HEPATOLOGY (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Reversion of hepatic stellate cell to a quiescent phenotype: From myth to reality?
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Kouichi Miura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma
Cun-Li Guo et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Tuanjie Li et al.
CANCER LETTERS (2012)
Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
Annie-Carole Tosello-Trampont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mechanisms of hepatic fibrogenesis
Ursula E. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Curcumin and Liver Cancer: A Review
Altaf S. Darvesh et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells
Laia Caja et al.
JOURNAL OF HEPATOLOGY (2011)
Kupffer cell activation is a causal factor for hepatic insulin resistance
Nicolas Lanthier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
Wan Huang et al.
DIABETES (2010)
Kupffer Cells Promote Hepatic Steatosis Via Interleukin-1β-Dependent Suppression of Peroxisome Proliferator-Activated Receptor α Activity
Rinke Stienstra et al.
HEPATOLOGY (2010)
Transforming Growth Factor-Beta Induces Senescence in Hepatocellular Carcinoma Cells and Inhibits Tumor Growth
Serif Senturk et al.
HEPATOLOGY (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Critical role of Kupffer cells in the management of diet-induced diabetes and obesity
Audrey M. Neyrinck et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
Tong Ding et al.
HUMAN PATHOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
FDA approves sorafenib for patients with inoperable liver cancer
Richard Peek et al.
GASTROENTEROLOGY (2008)
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis
Chantal A. Rivera et al.
JOURNAL OF HEPATOLOGY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance
Martina Berg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2
Yu-An Yang et al.
CANCER CELL (2006)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis:: suppression by surgery and the prophylactic use of a β-adrenergic antagonist and a prostaglandin synthesis inhibitor
R Melamed et al.
BRAIN BEHAVIOR AND IMMUNITY (2005)
Transforming growth factor-beta 1 marker of small hepatocellular as a useful serologic carcinoma
BC Song et al.
CANCER (2002)
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
A Limmer et al.
NATURE MEDICINE (2000)